Results 121 to 130 of about 8,627 (176)
In Vitro Selection of Specific DNA Aptamers Against the Anti-Coagulant Dabigatran Etexilate. [PDF]
Aljohani MM +7 more
europepmc +1 more source
Choice of Renal Function Estimator Influences Adverse Outcomes with Dabigatran Etexilate in Patients with Atrial Fibrillation. [PDF]
Simpson BH +3 more
europepmc +1 more source
Background: It has been estimated that major orthopaedic surgery has the highest risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) when compared with other surgery.
Cathal Walsh +3 more
core
Stability of repackaged dabigatran etexilate capsules in dose administration aids. [PDF]
Robertson SG, Glass BD.
europepmc +1 more source
Agent-specific bleeding signatures in non-hypertensive versus hypertensive patients exposed to oral anticoagulants: a real-world pharmacovigilance study. [PDF]
Feng Y +5 more
europepmc +1 more source
Design and rationale for the DIVERSITY study: An open-label, randomized study of dabigatran etexilate for pediatric venous thromboembolism. [PDF]
Albisetti M +14 more
europepmc +1 more source
The effect of oral dabigatran etexilate on bone density, strength, and microstructure in healthy mice. [PDF]
Brent MB, Thomsen JS, Brüel A.
europepmc +1 more source

